Drug Profile
Evatanepag
Alternative Names: CP-533,536Latest Information Update: 05 Nov 2023
Price :
$50
*
At a glance
- Originator Pfizer
- Class Pyridines; Small molecules
- Mechanism of Action Osteogenesis stimulants; Prostaglandin E EP2 receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Fracture
Most Recent Events
- 27 Sep 2010 Discontinued - Phase-II for Fracture in Australia (SC)
- 27 Sep 2010 Discontinued - Phase-II for Fracture in Bosnia-Herzegovina (SC)
- 27 Sep 2010 Discontinued - Phase-II for Fracture in Canada (SC)